Roivant ' s Anti-inflammatory Drug Shows Promise in Mid-stage Study Roivant ' s Anti-inflammatory Drug Shows Promise in Mid-stage Study

Roivant Sciences ' experimental drug to treat non-infectious uveitis helped reduce symptoms of the inflammatory eye disease in a mid-stage study, sending the biotech firm ' s...Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Ophthalmology Source Type: news